Are HIV positive patients resistant to statin therapy?
<p>Abstract</p> <p>Background</p> <p>Patients with HIV are subject to development of HIV metabolic syndrome characterized by dyslipidemia, lipodystrophy and insulin resistance secondary to highly active antiretroviral therapy (HAART). Rosuvastatin is a highly potent HMG...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2007-10-01
|
| Series: | Lipids in Health and Disease |
| Online Access: | http://www.lipidworld.com/content/6/1/27 |